Decision 2008/911/EC is amended as follows:
1.
Annex I is amended in accordance with Annex I to this Decision.
2.
Annex II is amended in accordance with Annex II to this Decision.
資料由法律人 LawPlayer整理提供·EU law / curated by LawPlayer from EUR-Lex
Decision 2008/911/EC is amended as follows:
1.
Annex I is amended in accordance with Annex I to this Decision.
2.
Annex II is amended in accordance with Annex II to this Decision.
This Decision is addressed to the Member States.
ANNEX I
In Annex I to Decision 2008/911/EC, the following is inserted:
—
‘Calendula officinalis L’ is inserted before Foeniculum vulgare Miller subsp. vulgare var. vulgare (Bitter fennel, fruit),
—
‘Pimpinella anisum L’ is inserted after Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (Sweet fennel, fruit).
ANNEX II
In Annex II to Decision 2008/911/EC, the following is inserted:
—
‘Calendula officinalis L’ is inserted before Foeniculum vulgare Miller subsp. vulgare var. vulgare (Bitter fennel, fruit)
‘COMMUNITY LIST ENTRY ON CALENDULA OFFICINALIS L
Scientific name of the plant
Calendula officinalis L.
Botanical family
Asteraceae
Herbal substance
Calendula flower
Common name in all EU official languages of herbal substance
—
BG (bălgarski): Невен, цвят
—
CS (čeština): Měsíčkový květ
—
DA (dansk): Morgenfrueblomst
—
DE (Deutsch): Ringelblumenblüten
—
EL (elliniká): Άνθος καλέντουλας
—
EN (English): Calendula flower
—
ES (español): Flor de caléndula
—
ET (eesti keel): Saialilleõisik
—
FI (suomi): Tarhakehäkukan kukka
—
FR (français): Souci
—
HU (magyar): A körömvirág virága
—
IT (italiano): Calendula fiore
—
LT (lietuvių kalba): Medetkų žiedai
—
LV (latviešu valoda): Kliņģerītes ziedi
—
MT (malti): Fjura calendula
—
NL (nederlands): Goudsbloem
—
PL (polski): Kwiat nagietka
—
PT (português): Flor de calêndula
—
RO (română): Floare de gălbenele (calendula)
—
SK (slovenčina): Nechtíkový kvet
—
SL (slovenščina): Cvet vrtnega ognjiča
—
SV (svenska): Ringblomma, blomma
—
IS (íslenska): Morgunfrú, blóm
—
NO (norsk): Ringblomst
Herbal preparation(s)
A.
Liquid extract (DER 1:1), extraction solvent ethanol 40-50 % (v/v).
B.
Liquid extract (DER 1:1,8-2,2), extraction solvent ethanol 40-50 % (v/v).
C.
Tincture (DER 1:5), extraction solvent ethanol 70-90 % (v/v).
European Pharmacopoeia monograph reference
Calendula flower – Calendulae flos (01/2005:1297)
Indication(s)
(a)
Traditional herbal medicinal product for the symptomatic treatment of minor inflammations of the skin (such as sunburn) and as an aid in healing of minor wounds.
(b)
Traditional herbal medicinal product for the symptomatic treatment of minor inflammations in the mouth or the throat.
The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use.
Type of tradition
European
Specified strength
Please see “Specified posology”.
Specified posology
Herbal preparations:
A.
Liquid extract (DER 1:1)
In semi-solid dosage forms: amount equivalent to 2-10 % herbal substance.
B.
Liquid extract (DER 1:1,8-2,2)
In semi-solid dosage forms: amount equivalent to 2-5 % herbal substance.
C.
Tincture (DER 1:5)
In compresses diluted at least 1:3 with freshly boiled water.
In semi-solid dosage forms: amount equivalent to 2-10 % herbal substance.
As a gargle or mouth rinse in a 2 % solution.
2 to 4 times daily
Indication (a)
The use is not recommended in children under 6 years of age (see below “Special warnings and precautions for use”).
Indication (b)
The use in children under 12 years of age is not recommended because there is no experience available (see below “Special warnings and precautions for use”).
Route of administration
Cutaneous and oromucosal use.
Duration of use or any restrictions on the duration of use
Compresses: remove after 30-60 minutes
All herbal preparations: If the symptoms persist after 1 week during the use of the medicinal product a doctor or a qualified health care practitioner should be consulted.
Any other information necessary for the safe use
Contraindications
Hypersensitivity to members of the Asteraceae ( Compositae ) family.
Special warnings and precautions for use
Indication (a)
The use in children under 6 years of age is not recommended because there is no experience available.
Indication (b)
The use in children under 12 years of age is not recommended because there is no experience available.
If signs of skin infection are observed, a doctor or a qualified health care practitioner should be consulted.
Interactions with other medicinal products and other forms of interaction
None reported.
Pregnancy and lactation
Safety during pregnancy and lactation has not been established.
In the absence of sufficient data, the use during pregnancy and lactation is not recommended.
Effects on ability to drive and use machines
Not relevant.
Undesirable effects
Skin sensitisation. The frequency is not known.
If other adverse reactions not mentioned above occur, a doctor or a qualified health care practitioner should be consulted.
Overdose
None reported.’
—
‘Pimpinella anisum L’ is inserted after Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (Sweet fennel, fruit)
‘COMMUNITY LIST ENTRY ON PIMPINELLA ANISUM L
Scientific name of the plant
Pimpinella anisum L.
Botanical family
Apiaceae
Herbal substance
Aniseed
Common name in all EU official languages of herbal substance
—
BG (bălgarski): Анасон, плод
—
CS (čeština): Anýzový plod
—
DA (dansk): Anisfrø
—
DE (Deutsch): Anis
—
EL (elliniká): Γλυκάνισο
—
EN (English): Aniseed
—
ES (español): Fruto de anís
—
ET (eesti keel): Aniis
—
FI (suomi): Anis
—
FR (français): Anis (fruit d)
—
HU (magyar): Ánizsmag
—
IT (italiano): Anice (Anice verde), frutto
—
LT (lietuvių kalba): Anyžių sėklos
—
LV (latviešu valoda): Anīsa sēklas
—
MT (malti): Frotta tal-Anisi
—
NL (nederlands): Anijsvrucht
—
PL (polski): Owoc anyżu
—
PT (português): Anis
—
RO (română): Fruct de anason
—
SK (slovenčina): Anízový plod
—
SL (slovenščina): Plod vrtnega janeža
—
SV (svenska): Anis
—
IS (íslenska): Anís
—
NO (norsk): Anis
Herbal preparation(s)
Dried aniseed, comminuted or crushed
European Pharmacopoeia monograph reference
Anisi fructus (01/2005:0262)
Indication(s)
(a)
Traditional herbal medicinal product for symptomatic treatment of mild, spasmodic gastro-intestinal complaints including bloating and flatulence.
(b)
Traditional herbal medicinal product used as an expectorant in cough associated with cold.
The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use.
Type of tradition
European
Specified strength
Please see “Specified posology”
Specified posology
Adolescents over 12 years of age, adults, elderly :
Indications (a) and (b)
1 to 3,5 g of whole or (freshly ( *1 ) ) comminuted or crushed aniseed in 150 ml of boiling water as a herbal tea
3 times daily
The use in children under 12 years is not recommended of age (see below “Special warnings and precautions for use”).
Route of administration
Oral use
Duration of use or any restrictions on the duration of use
Not to be taken for more than 2 weeks.
If the symptoms persist during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted.
Any other information necessary for the safe use
Contraindications
Hypersensitivity to the active substance or to Apiaceae ( Umbelliferae ) (caraway, celery, coriander, dill and fennel) or to anethole.
Special warnings and precautions for use
The use is not recommended in children under 12 years of age due to the lack of adequate data for safety assessment.
Interactions with other medicinal products and other forms of interaction
None reported.
Pregnancy and lactation
There are no data from the use of aniseed in pregnant patients.
It is unknown if aniseed constituents are excreted in human breast milk.
In the absence of sufficient data, the use during pregnancy and lactation is not recommended.
Effects on ability to drive and use machines
No studies on the effect on the ability to drive and use machines have been performed.
Undesirable effects
Allergic reactions to aniseed affecting the skin or the respiratory system may occur. The frequency is not known.
If other adverse reactions not mentioned above occur, a doctor or a qualified health care practitioner should be consulted.
Overdose
No case of overdose has been reported.
( *1 ) For commercial preparations of comminuted or crushed aniseed the applicant must carry out appropriate stability testing related to the content of essential oil components.’
Commission Decision of 28 July 2009 amending the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2009) 5804) (Text with EEA relevance) (EUR-Lex). Retrieved via LawPlayer, https://lawplayer.com/eu/act/32010D0028
© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.
本頁資料來源:EUR-Lex·整理提供:法律人 LawPlayer· lawplayer.com